Rebecca R. Laborde

Mutations and prognosis in primary myelofibrosis

A. M. Vannucchi, T L Lasho, Paola Guglielmelli et al. · Leukemia · 2013 · 739 citations

Hematological Malignancy, Hematology, Pathology +4

A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis

Ayalew Tefferi, Terra L. Lasho, Kebede H. Begna et al. · New England Journal of Medicine · 2015 · 317 citations · Full text

Long-term Functional and Oncologic Results of Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma

Eric J. Moore, Steven M. Olsen, Rebecca R. Laborde et al. · Mayo Clinic Proceedings · 2012 · 272 citations · Full text

Surgical Oncology, Medicine, Robotic Surgery +10

CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia

Animesh Pardanani, Terra L. Lasho, Rebecca R. Laborde et al. · Leukemia · 2013 · 248 citations · Full text

Hematological Malignancy, Specific Mutation, Medicine +10

Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis

Animesh Pardanani, Rebecca R. Laborde, Terra L. Lasho et al. · Leukemia · 2013 · 229 citations · Full text